ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,204, issued on Nov. 18, was assigned to CELAL BAYAR UNIVERSITESI DIGER MERKEZLER MUDURLUGU (Manisa, Turkey).

"Compound of element acid, which is in allotropic form, which enters into cellular interaction in some bone diseases" was invented by Hafize Seda Vatansever (Manisa, Turkey), Fatih Ozcan (Manisa, Turkey) and Ceyda Ozcan (Manisa, Turkey).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides usage of boric acid in a method of brittle bone disease treatment. In the present invention, moreover, there is a new brittle bone disease (osteogenesis imperfecta) in-vitro model for observing the effect of boric acid on brittle bone...